Loading…

Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro

The in vitro release of matrix-degrading proteinases from breast cancer cells is associated in part with shed membrane vesicles. To determine whether shed vesicles might play a similar role in ovarian cancer cells, we analyzed the shedding phenomenon in vivo and in vitro as well as the enzymatic con...

Full description

Saved in:
Bibliographic Details
Published in:Clinical & experimental metastasis 1999-03, Vol.17 (2), p.131
Main Authors: Dolo, V, D'Ascenzo, S, Violini, S, Pompucci, L, Festuccia, C, Ginestra, A, Vittorelli, M L, Canevari, S, Pavan, A
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 2
container_start_page 131
container_title Clinical & experimental metastasis
container_volume 17
creator Dolo, V
D'Ascenzo, S
Violini, S
Pompucci, L
Festuccia, C
Ginestra, A
Vittorelli, M L
Canevari, S
Pavan, A
description The in vitro release of matrix-degrading proteinases from breast cancer cells is associated in part with shed membrane vesicles. To determine whether shed vesicles might play a similar role in ovarian cancer cells, we analyzed the shedding phenomenon in vivo and in vitro as well as the enzymatic content of their vesicles. This is the first time that an immunoelectron microscopical analysis revealed membrane vesicles carrying tumor-associated antigen alpha-Folate Receptor (alpha-FR), circulating in biological fluids (ascites and serum) of an ovarian carcinoma patient. These vesicles were trapped in a fiber network with characteristic fibrin periodicity. An ovarian cancer cell line (CABA I) established from ascitic fluid cells of this patient, grew in Matrigel and formed tubular structures suggesting invasive capability. Immunofluorescence analysis demonstrated strong cytoplasmic staining of CABA I cells with anti-matrix metalloproteinase-9 (MMP-9) and anti-urokinase-type plasminogen activator (uPA) antibodies. CABA I cells shed membrane vesicles, which were morphologically similar to those identified in vivo, as determined by electron microscopy. Gelatin zymography of vesicles isolated both in vivo and in vitro revealed major gelatinolytic bands of the MMP family, identified as the zymogen and active forms of gelatinase B (MMP-9) and gelatinase A (MMP-2). By casein-plasminogen zymography we observed high-molecular weight (HMW)-uPA and plasmin bands. Incubation of purified vesicles from CABA I cells with Matrigel led to cleavage of Matrigel components. Taken together, our results point to a possible role of shed vesicles, both in vivo and in vitro, in proteolysis that mediates invasion and spread of ovarian epithelial carcinoma cells.
doi_str_mv 10.1023/A:1006500406240
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_214159596</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>387002061</sourcerecordid><originalsourceid>FETCH-LOGICAL-p135t-740a9c166e5624de7b8773041c0b77c5a03085c743a7bc3bfae34d4782966e103</originalsourceid><addsrcrecordid>eNo1kM1PwzAMxSMEYmNw5oYi7gXnq2m5TRNf0hAXOFdp6o1MbTqSrmL_PUEbJz_JPz_7mZBrBncMuLifPzCAXAFIyLmEEzJlSotMc52fkinwnGdQlMWEXMS4gYRpXZyTCQPJGAM1Jes3MwT3kzW4DqZxfk23oR_QeRMxUhOQxi9sqPO0w64OxiMdMTrbpm69p_1ogjOeWuMtBmqxbeMfPLqxp8Y3Bz2E_pKcrUwb8epYZ-Tz6fFj8ZIt359fF_NltmVCDZmWYErL8hxVytOgrgutRbrWQq21VQYEFMpqKYyurahXBoVspC54mWYYiBm5PfimGN87jEO16XfBp5UVZ5KpUpV5gm6O0K7usKm2wXUm7Kv_t4hfADVjug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214159596</pqid></control><display><type>article</type><title>Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro</title><source>Springer Nature</source><creator>Dolo, V ; D'Ascenzo, S ; Violini, S ; Pompucci, L ; Festuccia, C ; Ginestra, A ; Vittorelli, M L ; Canevari, S ; Pavan, A</creator><creatorcontrib>Dolo, V ; D'Ascenzo, S ; Violini, S ; Pompucci, L ; Festuccia, C ; Ginestra, A ; Vittorelli, M L ; Canevari, S ; Pavan, A</creatorcontrib><description>The in vitro release of matrix-degrading proteinases from breast cancer cells is associated in part with shed membrane vesicles. To determine whether shed vesicles might play a similar role in ovarian cancer cells, we analyzed the shedding phenomenon in vivo and in vitro as well as the enzymatic content of their vesicles. This is the first time that an immunoelectron microscopical analysis revealed membrane vesicles carrying tumor-associated antigen alpha-Folate Receptor (alpha-FR), circulating in biological fluids (ascites and serum) of an ovarian carcinoma patient. These vesicles were trapped in a fiber network with characteristic fibrin periodicity. An ovarian cancer cell line (CABA I) established from ascitic fluid cells of this patient, grew in Matrigel and formed tubular structures suggesting invasive capability. Immunofluorescence analysis demonstrated strong cytoplasmic staining of CABA I cells with anti-matrix metalloproteinase-9 (MMP-9) and anti-urokinase-type plasminogen activator (uPA) antibodies. CABA I cells shed membrane vesicles, which were morphologically similar to those identified in vivo, as determined by electron microscopy. Gelatin zymography of vesicles isolated both in vivo and in vitro revealed major gelatinolytic bands of the MMP family, identified as the zymogen and active forms of gelatinase B (MMP-9) and gelatinase A (MMP-2). By casein-plasminogen zymography we observed high-molecular weight (HMW)-uPA and plasmin bands. Incubation of purified vesicles from CABA I cells with Matrigel led to cleavage of Matrigel components. Taken together, our results point to a possible role of shed vesicles, both in vivo and in vitro, in proteolysis that mediates invasion and spread of ovarian epithelial carcinoma cells.</description><identifier>ISSN: 0262-0898</identifier><identifier>EISSN: 1573-7276</identifier><identifier>DOI: 10.1023/A:1006500406240</identifier><identifier>PMID: 10411105</identifier><identifier>CODEN: CEXMD2</identifier><language>eng</language><publisher>Netherlands: Springer Nature B.V</publisher><subject>Adenocarcinoma, Papillary - enzymology ; Biomarkers, Tumor - analysis ; Blotting, Western ; Cell Membrane - enzymology ; Cell Membrane - ultrastructure ; Female ; Fluorescent Antibody Technique ; Humans ; In Vitro Techniques ; Metalloendopeptidases - physiology ; Metalloendopeptidases - secretion ; Microscopy, Electron ; Middle Aged ; Ovarian Neoplasms - enzymology ; Plasminogen Activators - metabolism ; Tumor Cells, Cultured</subject><ispartof>Clinical &amp; experimental metastasis, 1999-03, Vol.17 (2), p.131</ispartof><rights>Copyright Kluwer Academic Publishers Mar 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10411105$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dolo, V</creatorcontrib><creatorcontrib>D'Ascenzo, S</creatorcontrib><creatorcontrib>Violini, S</creatorcontrib><creatorcontrib>Pompucci, L</creatorcontrib><creatorcontrib>Festuccia, C</creatorcontrib><creatorcontrib>Ginestra, A</creatorcontrib><creatorcontrib>Vittorelli, M L</creatorcontrib><creatorcontrib>Canevari, S</creatorcontrib><creatorcontrib>Pavan, A</creatorcontrib><title>Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro</title><title>Clinical &amp; experimental metastasis</title><addtitle>Clin Exp Metastasis</addtitle><description>The in vitro release of matrix-degrading proteinases from breast cancer cells is associated in part with shed membrane vesicles. To determine whether shed vesicles might play a similar role in ovarian cancer cells, we analyzed the shedding phenomenon in vivo and in vitro as well as the enzymatic content of their vesicles. This is the first time that an immunoelectron microscopical analysis revealed membrane vesicles carrying tumor-associated antigen alpha-Folate Receptor (alpha-FR), circulating in biological fluids (ascites and serum) of an ovarian carcinoma patient. These vesicles were trapped in a fiber network with characteristic fibrin periodicity. An ovarian cancer cell line (CABA I) established from ascitic fluid cells of this patient, grew in Matrigel and formed tubular structures suggesting invasive capability. Immunofluorescence analysis demonstrated strong cytoplasmic staining of CABA I cells with anti-matrix metalloproteinase-9 (MMP-9) and anti-urokinase-type plasminogen activator (uPA) antibodies. CABA I cells shed membrane vesicles, which were morphologically similar to those identified in vivo, as determined by electron microscopy. Gelatin zymography of vesicles isolated both in vivo and in vitro revealed major gelatinolytic bands of the MMP family, identified as the zymogen and active forms of gelatinase B (MMP-9) and gelatinase A (MMP-2). By casein-plasminogen zymography we observed high-molecular weight (HMW)-uPA and plasmin bands. Incubation of purified vesicles from CABA I cells with Matrigel led to cleavage of Matrigel components. Taken together, our results point to a possible role of shed vesicles, both in vivo and in vitro, in proteolysis that mediates invasion and spread of ovarian epithelial carcinoma cells.</description><subject>Adenocarcinoma, Papillary - enzymology</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Blotting, Western</subject><subject>Cell Membrane - enzymology</subject><subject>Cell Membrane - ultrastructure</subject><subject>Female</subject><subject>Fluorescent Antibody Technique</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Metalloendopeptidases - physiology</subject><subject>Metalloendopeptidases - secretion</subject><subject>Microscopy, Electron</subject><subject>Middle Aged</subject><subject>Ovarian Neoplasms - enzymology</subject><subject>Plasminogen Activators - metabolism</subject><subject>Tumor Cells, Cultured</subject><issn>0262-0898</issn><issn>1573-7276</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNo1kM1PwzAMxSMEYmNw5oYi7gXnq2m5TRNf0hAXOFdp6o1MbTqSrmL_PUEbJz_JPz_7mZBrBncMuLifPzCAXAFIyLmEEzJlSotMc52fkinwnGdQlMWEXMS4gYRpXZyTCQPJGAM1Jes3MwT3kzW4DqZxfk23oR_QeRMxUhOQxi9sqPO0w64OxiMdMTrbpm69p_1ogjOeWuMtBmqxbeMfPLqxp8Y3Bz2E_pKcrUwb8epYZ-Tz6fFj8ZIt359fF_NltmVCDZmWYErL8hxVytOgrgutRbrWQq21VQYEFMpqKYyurahXBoVspC54mWYYiBm5PfimGN87jEO16XfBp5UVZ5KpUpV5gm6O0K7usKm2wXUm7Kv_t4hfADVjug</recordid><startdate>199903</startdate><enddate>199903</enddate><creator>Dolo, V</creator><creator>D'Ascenzo, S</creator><creator>Violini, S</creator><creator>Pompucci, L</creator><creator>Festuccia, C</creator><creator>Ginestra, A</creator><creator>Vittorelli, M L</creator><creator>Canevari, S</creator><creator>Pavan, A</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>199903</creationdate><title>Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro</title><author>Dolo, V ; D'Ascenzo, S ; Violini, S ; Pompucci, L ; Festuccia, C ; Ginestra, A ; Vittorelli, M L ; Canevari, S ; Pavan, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p135t-740a9c166e5624de7b8773041c0b77c5a03085c743a7bc3bfae34d4782966e103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adenocarcinoma, Papillary - enzymology</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Blotting, Western</topic><topic>Cell Membrane - enzymology</topic><topic>Cell Membrane - ultrastructure</topic><topic>Female</topic><topic>Fluorescent Antibody Technique</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Metalloendopeptidases - physiology</topic><topic>Metalloendopeptidases - secretion</topic><topic>Microscopy, Electron</topic><topic>Middle Aged</topic><topic>Ovarian Neoplasms - enzymology</topic><topic>Plasminogen Activators - metabolism</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dolo, V</creatorcontrib><creatorcontrib>D'Ascenzo, S</creatorcontrib><creatorcontrib>Violini, S</creatorcontrib><creatorcontrib>Pompucci, L</creatorcontrib><creatorcontrib>Festuccia, C</creatorcontrib><creatorcontrib>Ginestra, A</creatorcontrib><creatorcontrib>Vittorelli, M L</creatorcontrib><creatorcontrib>Canevari, S</creatorcontrib><creatorcontrib>Pavan, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Clinical &amp; experimental metastasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dolo, V</au><au>D'Ascenzo, S</au><au>Violini, S</au><au>Pompucci, L</au><au>Festuccia, C</au><au>Ginestra, A</au><au>Vittorelli, M L</au><au>Canevari, S</au><au>Pavan, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro</atitle><jtitle>Clinical &amp; experimental metastasis</jtitle><addtitle>Clin Exp Metastasis</addtitle><date>1999-03</date><risdate>1999</risdate><volume>17</volume><issue>2</issue><spage>131</spage><pages>131-</pages><issn>0262-0898</issn><eissn>1573-7276</eissn><coden>CEXMD2</coden><abstract>The in vitro release of matrix-degrading proteinases from breast cancer cells is associated in part with shed membrane vesicles. To determine whether shed vesicles might play a similar role in ovarian cancer cells, we analyzed the shedding phenomenon in vivo and in vitro as well as the enzymatic content of their vesicles. This is the first time that an immunoelectron microscopical analysis revealed membrane vesicles carrying tumor-associated antigen alpha-Folate Receptor (alpha-FR), circulating in biological fluids (ascites and serum) of an ovarian carcinoma patient. These vesicles were trapped in a fiber network with characteristic fibrin periodicity. An ovarian cancer cell line (CABA I) established from ascitic fluid cells of this patient, grew in Matrigel and formed tubular structures suggesting invasive capability. Immunofluorescence analysis demonstrated strong cytoplasmic staining of CABA I cells with anti-matrix metalloproteinase-9 (MMP-9) and anti-urokinase-type plasminogen activator (uPA) antibodies. CABA I cells shed membrane vesicles, which were morphologically similar to those identified in vivo, as determined by electron microscopy. Gelatin zymography of vesicles isolated both in vivo and in vitro revealed major gelatinolytic bands of the MMP family, identified as the zymogen and active forms of gelatinase B (MMP-9) and gelatinase A (MMP-2). By casein-plasminogen zymography we observed high-molecular weight (HMW)-uPA and plasmin bands. Incubation of purified vesicles from CABA I cells with Matrigel led to cleavage of Matrigel components. Taken together, our results point to a possible role of shed vesicles, both in vivo and in vitro, in proteolysis that mediates invasion and spread of ovarian epithelial carcinoma cells.</abstract><cop>Netherlands</cop><pub>Springer Nature B.V</pub><pmid>10411105</pmid><doi>10.1023/A:1006500406240</doi></addata></record>
fulltext fulltext
identifier ISSN: 0262-0898
ispartof Clinical & experimental metastasis, 1999-03, Vol.17 (2), p.131
issn 0262-0898
1573-7276
language eng
recordid cdi_proquest_journals_214159596
source Springer Nature
subjects Adenocarcinoma, Papillary - enzymology
Biomarkers, Tumor - analysis
Blotting, Western
Cell Membrane - enzymology
Cell Membrane - ultrastructure
Female
Fluorescent Antibody Technique
Humans
In Vitro Techniques
Metalloendopeptidases - physiology
Metalloendopeptidases - secretion
Microscopy, Electron
Middle Aged
Ovarian Neoplasms - enzymology
Plasminogen Activators - metabolism
Tumor Cells, Cultured
title Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T12%3A14%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Matrix-degrading%20proteinases%20are%20shed%20in%20membrane%20vesicles%20by%20ovarian%20cancer%20cells%20in%20vivo%20and%20in%20vitro&rft.jtitle=Clinical%20&%20experimental%20metastasis&rft.au=Dolo,%20V&rft.date=1999-03&rft.volume=17&rft.issue=2&rft.spage=131&rft.pages=131-&rft.issn=0262-0898&rft.eissn=1573-7276&rft.coden=CEXMD2&rft_id=info:doi/10.1023/A:1006500406240&rft_dat=%3Cproquest_pubme%3E387002061%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p135t-740a9c166e5624de7b8773041c0b77c5a03085c743a7bc3bfae34d4782966e103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=214159596&rft_id=info:pmid/10411105&rfr_iscdi=true